High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.

Saved in:
Bibliographic Details
Title: High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.
Authors: Mundle ST; Discovery North America, Sanofi Pasteur, Cambridge, Massachusetts, United States of America. sophia.mundle@sanofipasteur.com, Hernandez H, Hamberger J, Catalan J, Zhou C, Stegalkina S, Tiffany A, Kleanthous H, Delagrave S, Anderson SF
Source: PloS one [PLoS One] 2013; Vol. 8 (2), pp. e57224. Date of Electronic Publication: 2013 Feb 26.
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0057224